How is Wee1 phosphorylated?
It is inactivated by phosphorylation through Wee1 and activated by the phosphatase Cdc25C. Cdc25C in turn is activated by Polo kinase and inactivated by Chk1. Thus in S. pombe Wee1 regulation is mainly under the control of phosphorylation through the polarity kinase, Pom1’s, pathway including Cdr2 and Cdr1.
How does Wee1 inhibitor work?
WEE1/PKMYT1 kinase inhibition causes G2/M cell cycle checkpoint override, premature mitotic entry, and cell death during mitosis, through a mechanism generally known as mitotic catastrophe (Fig.
How does Wee1 regulate the cell cycle?
Wee1 directly interacts with histone H2B to halt histone transcription at the end of S phase. It regulates the G2-M transition by phosphorylating CDK2 to inactivate the CDK2/cyclin B complex to terminate the cell cycle.
What does Wee1 kinase do?
Wee1 also plays a critical role in the proper timing of cell division, modulating the activity of cyclin-dependent kinases 1 and 2 through inhibitory phosphorylation of conserved tyrosine15 residues on both kinases, thereby controlling entry into mitosis and DNA replication during S phase.
How does WEE1 influence MPF?
MPF activity can be regulated by reversible association with the Cdk inhibitor Rum1, as well as by phosphorylation and dephosphorylation by the inhibitory kinase Wee1 and the activating phosphatase Cdc25, respectively. MPF inhibits Rum1 and Wee1, while it activates Cdc25.
Is CAK a kinase?
In budding yeast, CAK is a monomeric protein kinase and is referred to as Cak1. Cak1 is distantly homologous to Cdks. Cak1 localizes to the cytoplasm and is responsible for Cdk activation.
Is CAK an inhibitor of cell division?
Several lines of evidence support the role of CAK as an important cell cycle regulator, becoming a target for the design of inhibitors to regulate the cell cycle, especially in diseases such as cancer (24–27). In addition to activating Cdks, CAK regulates transcription (28).
What happens if DNA damage is discovered at the G2 checkpoint?
If errors or damage are detected, the cell will pause at the G 2start subscript, 2, end subscript checkpoint to allow for repairs. If the checkpoint mechanisms detect problems with the DNA, the cell cycle is halted, and the cell attempts to either complete DNA replication or repair the damaged DNA.
How is CAK activated?
Catalytic activity Cdk activation requires two steps. First, cyclin must bind to the Cdk. In the second step, CAK must phosphorylate the cyclin-Cdk complex on the threonine residue 160, which is located in the Cdk activation segment.
What is inhibitory phosphorylation?
Inhibitory phosphorylation of the catalytic subunit of CDK is part of the S phase checkpoint control in response to damage or incompletely replicated DNA in several organisms. For instance, S. pombe, A. nidulans and human cells are dependent of this regulation. In contrast, S.
What is the function of Wee1 kinase?
The Wee1 kinase regulates entry into mitosis, by negatively controlling CDK1 and 2. In a similar fashion to ATR and Chk1, it is active during normal unperturbed cell division, playing a role in the maintenance of genome integrity.
Can Chk1/Chk2 and Wee1 be targeted together?
Synergism in targeting CHK1/CHK2 and WEE1 together in NPC cells A general approach for target therapies is to utilize minimum drug concentrations to reduce non-specific effects and general toxicity. A growing body of evidence indicates that targeting CHK1/CHK2 and WEE1 together can increase cytotoxicity in a variety of cancer cell types [16].
How do CHk1 inhibitors work?
CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress While effective anti-cancer drugs targeting the CHK1 kinase are advancing in the clinic, drug resistance is rapidly emerging.
What is Wee1 and why is it important?
Wee1 is downstream of Chk1 and Chk2, and thus it is anticipated that Wee1 inhibitors will also increase the activity of DNA damaging anticancer therapies, and that this effect will be specific for cells that lack the ability to arrest at the G1/S checkpoint, e.g. through p53 mutation.